Article Details
Retrieved on: 2021-04-19 08:28:18
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The funding will support the progression of Phico's lead product SASPject™ PT3.9 through clinical trials with $5.3 million USD (circa. £3.8 million GBP) ...
Article found on: uk.finance.yahoo.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here